CYTOKINETICS INCORPORATED - COMMON STOCK

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 янв 2025 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

03 янв 2025 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

23 дек 2024 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

19 дек 2024 23:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 дек 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

03 дек 2024 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Participate in December Investor Conferences

02 дек 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

02 дек 2024 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan

19 ноя 2024 01:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

16 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

16 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference

12 ноя 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089

11 ноя 2024 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Reports Third Quarter 2024 Financial Results

06 ноя 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024

05 ноя 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 ноя 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Announce Third Quarter Results on November 6, 2024

23 окт 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day

16 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 окт 2024 15:00:00 Источник Nasdaq GlobeNewswire

Cytokinetics to Host Investor & Analyst Day on October 16, 2024

02 окт 2024 15:00:00 Источник Nasdaq GlobeNewswire